Shin Byeong-Kwon, Kim Kun Yung, Han Young-Min, Lee Da Eul
Department of Radiology, Jeonbuk National University Hospital, Jeonju, Korea.
Department of Radiology, Seoul National University Bundang Hospital, Seognam, Korea.
Eur Radiol. 2025 May;35(5):2508-2518. doi: 10.1007/s00330-024-11152-1. Epub 2024 Oct 29.
To evaluate the impact of intraprocedural cone-beam CT (CBCT) aortography on culprit artery identification and clinical outcomes in patients undergoing bronchial artery embolization (BAE).
Two hundred eighty-two patients with 317 BAE procedures were retrospectively reviewed. Patients who underwent preprocedural chest CT angiography (CTA) without intraprocedural CBCT aortography were categorized as Group A (n = 177). Patients who underwent both preprocedural chest CTA and intraprocedural CBCT aortography were categorized as Group B (n = 105). Whether CBCT can provide improved culprit artery identification and whether this improvement has a clinical impact were evaluated by comparing the two Groups.
In Group B, CBCT aortography detected more culprit non-bronchial systemic arteries originating from the subclavian arteries compared to chest CTA (16 vs 3, p = 0.026), and the average number of embolized vessels was significantly higher than in Group A (2.47 ± 1.61 vs 2.03 ± 1.17, p = 0.016), while the procedure time was shorter (37.4 ± 22.0 vs 43.6 ± 22.7 min, p = 0.024). The recurrent hemoptysis rate was lower in Group B (17.5% vs 8.7%, p = 0.041), and the proportion of patients requiring subsequent procedures was significantly lower (12.4% vs 4.8%, p = 0.035). The changes in estimated glomerular filtration rate before and 3 days after the procedure (0.1 ± 12.8 vs 0.3 ± 11.0 mL/min/1.73 m, p = 0.909) and total dose area product (DAP, 6119.5 ± 5725.7 vs 6906.2 ± 5978.6 uGym, p = 0.279) were not significantly different between the two groups.
BAE with intraprocedural CBCT aortography enabled the embolization of more culprit arteries, leading to lower recurrent hemoptysis rates without increasing the risk of renal deterioration and radiation hazards when compared to procedures without it.
Question Does intraprocedural CBCT aortography improve culprit artery detection and clinical outcomes in BAE for hemoptysis? Findings CBCT aortography significantly improved the detection of additional culprit arteries, especially from non-bronchial systemic arteries, increasing the number of vessels treated during BAE. Clinical relevance Using CBCT aortography during BAE results in better long-term outcomes by reducing recurrent hemoptysis and the need for additional procedures, without increasing the risk of renal impairment.
评估术中锥形束CT(CBCT)血管造影对支气管动脉栓塞术(BAE)患者责任动脉识别及临床结局的影响。
回顾性分析282例患者的317例BAE手术。术前接受胸部CT血管造影(CTA)但未行术中CBCT血管造影的患者分为A组(n = 177)。术前接受胸部CTA及术中CBCT血管造影的患者分为B组(n = 105)。通过比较两组评估CBCT能否更好地识别责任动脉以及这种改善是否具有临床影响。
在B组中,与胸部CTA相比,CBCT血管造影检测到更多起源于锁骨下动脉的非支气管体循环责任动脉(16例对3例,p = 0.026),栓塞血管的平均数量显著高于A组(2.47±1.61对2.03±1.17,p = 0.016),而手术时间更短(37.4±22.0对43.6±22.7分钟,p = 0.024)。B组咯血复发率更低(17.5%对8.7%,p = 0.041),需要后续手术的患者比例显著更低(12.4%对4.8%,p = 0.035)。两组术前及术后3天估计肾小球滤过率的变化(0.1±12.8对0.3±11.0 mL/min/1.73 m²,p = 0.909)和总剂量面积乘积(DAP,6119.5±5725.7对6906.2±5978.6 uGym,p = 0.279)无显著差异。
与未使用术中CBCT血管造影的手术相比,术中使用CBCT血管造影的BAE能够栓塞更多责任动脉,降低咯血复发率,且不增加肾脏恶化风险和辐射危害。
问题 术中CBCT血管造影能否改善BAE治疗咯血时责任动脉的检测及临床结局? 发现 CBCT血管造影显著改善了额外责任动脉的检测,尤其是非支气管体循环动脉,增加了BAE期间治疗的血管数量。 临床意义 在BAE期间使用CBCT血管造影可通过降低咯血复发率和减少额外手术需求改善长期结局,且不增加肾功能损害风险。